Pharmacologic Substance
raloxifene
ral·ox·i·fene
Brand Names:
Evista
Effect:
Bone Resorption Inhibition; Cholesterol Metabolism Alteration
May Prevent:
Osteoporosis, Postmenopausal
May Treat:
Osteoporosis, Postmenopausal
More Information:
Definitions related to raloxifene:
-
A selective benzothiophene estrogen receptor modulator (SERM). Raloxifene binds to estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect. This agent functions as an estrogen agonist in some tissues (bones, lipid metabolism) and as an estrogen antagonist in others (endometrium and breasts), with the potential for producing some of estrogen's beneficial effects without producing its adverse effects. (NCI04)NCI ThesaurusU.S. National Cancer Institute, 2021
-
A selective estrogen receptor modulator; has both agonist and antagonist estrogen action.CRISP ThesaurusNational Institutes of Health, 2006
-
The active ingredient in a drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of the disease or who have osteoporosis. It is also used to prevent and treat osteoporosis in postmenopausal women. It is also being studied in the prevention of breast cancer in certain premenopausal women and in the prevention and treatment of other conditions. Raloxifene blocks the effects of the hormone estrogen in the breast and increases the amount of calcium in bone. It is a type of selective estrogen receptor modulator (SERM).NCI Dictionary of Cancer TermsU.S. National Cancer Institute, 2021
Return to OpenMD Medical Dictionary
> R
This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.